Medherant Signs License Agreement With Bostik And Secures Seed Investment From Mercia For Development Of Next Generation Transdermal Drug Delivery Systems

8th June 2015
New bio-adhesive company Medherant, founded by Warwick Ventures for the University of Warwick, UK, in 2014, has signed a license agreement with the leading global adhesive specialists Bostik.
General News

Pages